Absolutely, I think it's about strategic accumulation! 3 - 4 months ago, with prices between 5-6c, I asked the question: 'When are ATL1102's pivotal Phase 2b trial results, regulatory nods, and market debut expected, and how does this align with the current financial strategy?' The timing couldn't be more perfect for accumulation at rock-bottom prices.
Let's accumulate slowly (no rush yet) and anticipate the adrenaline rush: the first surge in April with the announcement of full patient recruitment (finger cross that it shall be achieved), followed by a monumental leap in Oct/Nov '24 as trial results unveil. We're on the brink of something monumental.
Anyone bother to do the countdown till Oct 24?? Be patient as the real big pump should come and it should happen in 2024! Stay tuned
per-chart, page-124
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.001(1.01%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.8¢ | 10.0¢ | $85.75K | 839.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 816255 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 275536 | 3 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |